Published in Arthritis Rheum on November 01, 2000
Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol (2015) 1.01
Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole. CEN Case Rep (2016) 0.75
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature (1997) 8.86
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum (2001) 3.15
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor. Science (1989) 2.48
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
Key role for sulfur in peptide metabolism and in regulation of three hydrogenases in the hyperthermophilic archaeon Pyrococcus furiosus. J Bacteriol (2001) 2.12
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum (2000) 1.89
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res (2000) 1.81
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum (2000) 1.57
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis. Arthritis Rheum (1999) 1.47
FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO. J Biol Chem (1998) 1.42
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med (1997) 1.40
Continuous hemofiltration. N Engl J Med (1997) 1.40
Heterotopic ossification in the setting of neuromuscular blockade. Arthritis Rheum (1997) 1.37
Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J Clin Immunol (2005) 1.36
Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol (1997) 1.35
The solid-solution partitioning of heavy metals (Cu, Zn, Cd, Pb) in upland soils of England and Wales. Environ Pollut (2003) 1.32
Development of a provisional core set of response measures for clinical trials of systemic sclerosis. Ann Rheum Dis (2007) 1.26
Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol (2006) 1.26
UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett (1999) 1.26
TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol (1999) 1.25
Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol (2001) 1.19
Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int (1999) 1.11
Detection of two forms of GP330. Their role in Heymann nephritis. Am J Pathol (1993) 1.11
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci U S A (2000) 1.08
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum (1998) 1.05
The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med (1996) 1.04
Colchicine-induced redistribution of an apical membrane glycoprotein (gp330) in proximal tubules. Am J Physiol (1989) 1.03
Analytic assessment of the various bioimpedance methods used to estimate body water. J Appl Physiol (1985) (1998) 1.02
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol (2014) 0.99
Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. J Biol Chem (2000) 0.99
Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2013) 0.98
Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation. FASEB J (2000) 0.98
Homology requirements for ligation and strand exchange by the FLP recombinase. J Biol Chem (1995) 0.98
Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. Nucleic Acids Res (1996) 0.98
Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol (2011) 0.98
Impact of endotoxin on UCP homolog mRNA abundance, thermoregulation, and mitochondrial proton leak kinetics. Am J Physiol Endocrinol Metab (2000) 0.97
Effect of household land management on cropland topsoil organic carbon storage at plot scale in a red earth soil area of South China. J Agric Sci (2011) 0.95
Mutations of the FLP recombinase gene that cause a deficiency in DNA bending and strand cleavage. J Biol Chem (1993) 0.94
Identity of Wegener's autoantigen (p29) with proteinase 3 and myeloblastin. Blood (1990) 0.93
Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology (1992) 0.92
Prevalence and awareness of diabetes mellitus among a rural population in China: results from Liaoning Province. Diabet Med (2014) 0.91
[The significance of detection of Helicobacter pylori in saliva]. Zhonghua Nei Ke Za Zhi (1999) 0.91
Overexpression of the human 2-oxoglutarate carrier lowers mitochondrial membrane potential in HEK-293 cells: contrast with the unique cold-induced mitochondrial carrier CGI-69. Biochem J (2001) 0.91
How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors. Transplant Proc (2008) 0.89
Surface modification of Ti-6Al-4V alloy for biomineralization and specific biological response: Part I, inorganic modification. J Mater Sci Mater Med (2011) 0.88
Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology (1997) 0.88
Biomechanical evaluation of bone-porous material interfaces. J Biomed Mater Res (1973) 0.87
Location of gp330/alpha 2-m receptor-associated protein (alpha 2-MRAP) and its binding sites in kidney: distribution of endogenous alpha 2-MRAP is modified by tissue processing. Eur J Cell Biol (1993) 0.87
Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens (1999) 0.87
Accumulation of alpha-keto acids as essential components in cyanide assimilation by Pseudomonas fluorescens NCIMB 11764. Appl Environ Microbiol (1998) 0.87
Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjögren's syndrome. Arthritis Rheum (1992) 0.86
Assessment of kidney involvement. Clin Exp Rheumatol (2003) 0.86
ANCA-associated small vessel vasculitis presenting with ischemic optic neuropathy. Neurology (2004) 0.85
Long-term self-renewal of human pluripotent stem cells on peptide-decorated poly(OEGMA-co-HEMA) brushes under fully defined conditions. Acta Biomater (2013) 0.85
Amphibole fibres in Chinese chrysotile asbestos. Ann Occup Hyg (2001) 0.85
Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol (1993) 0.84
[An epidemiologic study of bowel habit in adult non-patient population in Beijing area]. Zhonghua Yi Xue Za Zhi (2001) 0.84
Compensatory changes in the retained kidney after nephrectomy in a living related donor. Transplant Proc (2012) 0.83
Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 0.83
Severe hyponatremia associated with combined pancreatic and renal transplantation. Transplantation (1989) 0.82
Stimulatory role of substance P on gonadotropin release in ovariectomized rats. Neuroendocrinology (1990) 0.82
Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes. Occup Environ Med (2001) 0.82
Leukocyte 8-hydroxydeoxyguanosine and aromatic DNA adduct in coke-oven workers with polycyclic aromatic hydrocarbon exposure. Int Arch Occup Environ Health (2003) 0.81
Identification and characterisation of tobacco microRNA transcriptome using high-throughput sequencing. Plant Biol (Stuttg) (2015) 0.81
Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur J Biochem (1999) 0.81
Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration. Clin Nephrol (2006) 0.81
Fas expression prevents cholangiocarcinoma tumor growth. J Gastrointest Surg (2000) 0.79
[p53 gene mutation in hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi (1998) 0.79
Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1. J Mol Cell Cardiol (1990) 0.79
Loss of antigens associated with the apical endocytotic pathway in proximal tubules from rats with heymann nephritis. Am J Pathol (1991) 0.78
[Potential role of gut peptides in stress-induced colonic motor disorder]. Zhonghua Yi Xue Za Zhi (1997) 0.78
Processing cord blood from premature infants into autologous red-blood-cell products for transfusion. Vox Sang (2010) 0.77
Effects of sterilization and storage on the properties of ALP-grafted biomaterials for prosthetic and bone tissue engineering applications. Biomed Mater (2012) 0.77
[Antithrombotic effect of daphnetin in the rat]. Yao Xue Xue Bao (1986) 0.77
Aromatic DNA adducts in coke-oven workers, in relation to exposure, lifestyle and genetic polymorphism of metabolic enzymes. Int Arch Occup Environ Health (2000) 0.77
[The establishment of TNBS-induced experimental colitis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (1998) 0.77
[Lactulose hydrogen breath test in small intestinal bacterial overgrowth]. Zhonghua Nei Ke Za Zhi (1995) 0.77
ANCA-positive vasculitis associated with allopurinol therapy. Clin Exp Rheumatol (1999) 0.77
The role of Zn in the interplay among Langmuir-Blodgett multilayer and myelin basic protein: a quantitative analysis of XANES spectra. Biophys Chem (2004) 0.76
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Clin Exp Rheumatol (2009) 0.76
Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology (1999) 0.76
ANCA test in ophthalmic inflammatory disease. Int Ophthalmol Clin (1994) 0.75
c-ANCA as a marker of Wegener's disease. Lancet (1996) 0.75
Wegener granulomatosis. Ann Intern Med (1992) 0.75
Influence of a donor quality score on pancreas transplant survival in the Eurotransplant area. Transplant Proc (2008) 0.75
Role of substance P in suppressing growth hormone release in the rat. Proc Natl Acad Sci U S A (1989) 0.75